These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Optical coherence tomography for age-related macular degeneration and diabetic macular edema: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2009; 9(13):1-22. PubMed ID: 23074517 [TBL] [Abstract][Full Text] [Related]
6. Aging and Vision. Alavi MV Adv Exp Med Biol; 2016; 854():393-9. PubMed ID: 26427437 [TBL] [Abstract][Full Text] [Related]
7. Measurement of the Inner Macular Layers for Monitoring of Glaucoma: Confounding Effects of Age-Related Macular Degeneration. Chew L; Mohammadzadeh V; Mohammadi M; Toriz V; Rosa N; Gorin MB; Amini N; Nouri-Mahdavi K Ophthalmol Glaucoma; 2023; 6(1):68-77. PubMed ID: 35750324 [TBL] [Abstract][Full Text] [Related]
8. Age-related macular degeneration--emerging pathogenetic and therapeutic concepts. Gehrs KM; Anderson DH; Johnson LV; Hageman GS Ann Med; 2006; 38(7):450-71. PubMed ID: 17101537 [TBL] [Abstract][Full Text] [Related]
9. Genetic Risk Assessment of Degenerative Eye Disease (GRADE): study protocol of a prospective assessment of polygenic risk scores to predict diagnosis of glaucoma and age-related macular degeneration. Hollitt GL; Qassim A; Thomson D; Schmidt JM; Nguyen TT; Landers J; MacGregor S; Siggs OM; Souzeau E; Craig JE BMC Ophthalmol; 2023 Oct; 23(1):431. PubMed ID: 37875865 [TBL] [Abstract][Full Text] [Related]
10. Age-related macular degeneration and myeloproliferative neoplasms - A common pathway. Liisborg C Acta Ophthalmol; 2022 Oct; 100 Suppl 271(Suppl 271):3-35. PubMed ID: 36200281 [TBL] [Abstract][Full Text] [Related]
11. Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28. Cukras C; Agrón E; Klein ML; Ferris FL; Chew EY; Gensler G; Wong WT; Ophthalmology; 2010 Mar; 117(3):489-99. PubMed ID: 20079925 [TBL] [Abstract][Full Text] [Related]
12. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Age-Related Eye Disease Study Research Group Arch Ophthalmol; 2001 Oct; 119(10):1417-36. PubMed ID: 11594942 [TBL] [Abstract][Full Text] [Related]
13. Influence of experimental chronic high-pressure glaucoma on age-related macular degeneration in rhesus monkeys. Jonas JB; Hayreh SS Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2972-7. PubMed ID: 10967053 [TBL] [Abstract][Full Text] [Related]
14. Laser treatment of drusen to prevent progression to advanced age-related macular degeneration. Virgili G; Michelessi M; Parodi MB; Bacherini D; Evans JR Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD006537. PubMed ID: 26493180 [TBL] [Abstract][Full Text] [Related]
15. Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. Seddon JM; Reynolds R; Yu Y; Daly MJ; Rosner B Ophthalmology; 2011 Nov; 118(11):2203-11. PubMed ID: 21959373 [TBL] [Abstract][Full Text] [Related]
19. Phenotypic Characterization of Complement Factor H R1210C Rare Genetic Variant in Age-Related Macular Degeneration. Ferrara D; Seddon JM JAMA Ophthalmol; 2015 Jul; 133(7):785-91. PubMed ID: 25880396 [TBL] [Abstract][Full Text] [Related]
20. Routine eye examinations for persons 20-64 years of age: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2006; 6(15):1-81. PubMed ID: 23074485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]